Literature DB >> 33927356

A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options.

Jason Bacharach1, Wendy W Lee2, Andrew R Harrison3, Thomas F Freddo4.   

Abstract

Blepharoptosis (ptosis) is among the most common disorders of the upper eyelid encountered in both optometric and ophthalmic practice. The unilateral or bilateral drooping of the upper eyelid that characterises ptosis can affect appearance and impair visual function, both of which can negatively impact quality of life. While there are several known forms of congenital ptosis, acquired ptosis (appearing later in life, due to a variety of causes) is the predominant form of the condition. This review summarises the prevalence, causes, identification, differential diagnosis, and treatment of acquired ptosis. Particular attention is paid to the differential diagnosis of acquired ptosis and emerging treatment options, including surgical and pharmacologic approaches.

Entities:  

Year:  2021        PMID: 33927356     DOI: 10.1038/s41433-021-01547-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  65 in total

1.  The psychological well-being and appearance concerns of patients presenting with ptosis.

Authors:  H S Richards; E Jenkinson; N Rumsey; P White; H Garrott; H Herbert; F Kalapesi; R A Harrad
Journal:  Eye (Lond)       Date:  2013-12-20       Impact factor: 3.775

2.  Prevalence and associated factors of blepharoptosis in Korean adult population: The Korea National Health and Nutrition Examination Survey 2008-2011.

Authors:  M H Kim; J Cho; D Zhao; K I Woo; Y-D Kim; S Kim; S W Yang
Journal:  Eye (Lond)       Date:  2017-03-24       Impact factor: 3.775

3.  Modified visual field test for ptosis surgery (Leicester Peripheral Field Test).

Authors:  S F Ho; A Morawski; R Sampath; J Burns
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

Review 4.  Evaluation and management of unilateral ptosis and avoiding contralateral ptosis.

Authors:  Christopher I Zoumalan; Richard D Lisman
Journal:  Aesthet Surg J       Date:  2010 May-Jun       Impact factor: 4.283

5.  Epidemiology of oculoplastic conditions: the Singapore experience.

Authors:  Marcus Chun Jin Tan; Stephanie Young; Shantha Amrith; Gangadhara Sundar
Journal:  Orbit       Date:  2012-04

6.  Severity of visual field loss and health-related quality of life.

Authors:  Roberta McKean-Cowdin; Rohit Varma; Joanne Wu; Ron D Hays; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2007-04-02       Impact factor: 5.258

7.  A community survey of ptosis of the eyelid and pupil size of elderly people.

Authors:  G V Sridharan; R C Tallis; B Leatherbarrow; W M Forman
Journal:  Age Ageing       Date:  1995-01       Impact factor: 10.668

8.  Comparison of automated and manual perimetry in patients with blepharoptosis.

Authors:  Saba T Alniemi; Noelene K Pang; John J Woog; Elizabeth A Bradley
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Sep-Oct       Impact factor: 1.746

Review 9.  Ptosis: causes, presentation, and management.

Authors:  Josef Finsterer
Journal:  Aesthetic Plast Surg       Date:  2003-08-21       Impact factor: 2.326

10.  The prevalence of ptosis in an Iranian adult population.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Mohammad Hassan Emamian; Abbasali Yekta; Ali Jafari; Payam Nabovati; Akbar Fotouhi
Journal:  J Curr Ophthalmol       Date:  2016-06-11
View more
  2 in total

1.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

2.  A Fully Automatic Postoperative Appearance Prediction System for Blepharoptosis Surgery with Image-based Deep Learning.

Authors:  Yiming Sun; Xingru Huang; Qianni Zhang; Sang Yeul Lee; Yaqi Wang; Kai Jin; Lixia Lou; Juan Ye
Journal:  Ophthalmol Sci       Date:  2022-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.